Dry Eye Syndrome Treatment Market, by Product Type (Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plug, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Supermarket/ Hypermarket, Other Stores, and Onlin

Dry Eye Syndrome Treatment Market, by Product Type (Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plug, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Supermarket/ Hypermarket, Other Stores, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Dry eye syndrome (DES) is also known as keratisis sicca and keratoconjunctivitis sicca. Patients suffering from DES show damage to the ocular surface, instability in the tear film, and visual disturbance. Tear film covers the ocular surface which is made up of three intertwined layers, a superficial lipid layer produced by meibomian glands assist in reducing tear evaporation and uniform tear spreading, middle thick aqueous layer produced from lacrimal glands, and the innermost hydrophilic mucin layer produced from goblet cells of conjunctiva and epithelium of ocular surface.
Market Dynamics
New dry eye therapies are introduced in the market with several new medications in the pipeline seeking approval. Strong product pipeline offers great market growth opportunity as approval of numerous pipeline products is expected to drive the market growth during the forecast period. In August 2018, Sun Pharma received approval for Cequa (cyclosporine ophthalmic solution) 0.09% from the U.S. FDA. The drug is indicated to increase tear production in patients with dry eye disease. Cequa is the only approved cyclosporine product that incorporates a nanomicellar technology and allows better penetration of the active molecule into the ocular tissues. Moreover, in January 2018, Shire plc. received FDA approval for Xiidra (lifitegrast ophthalmic solution 5%), a twice-daily eye drop solution for dry eye disease in adults in Canada. The drug was initially approved by the U.S. FDA in 2016. Thus, product approvals are expected to provide an opportunity for manufacturers to introduce novel therapies in the market.

Key features of the study:
This report provides in-depth analysis of the dry eye syndrome treatment market, market size (US$ Million) and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global dry eye syndrome treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study are Allergan Plc., Novartis AG, Bausch Health Companies, Inc., Johnson and Johnson Vision Care Inc., I-Med Pharma Inc., Santen Pharmaceuticals Co. Ltd., AFT Pharmaceuticals, Novaliq GmBH, Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, end user upgrades, market expansion, and marketing tactics
The global dry eye syndrome treatment market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for dry eye Syndrome Treatment Market, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the dry eye syndrome treatment market would provide stakeholders vital inputs to make strategic decisions accordingly.
Detailed Segmentation:
Global Dry Eye Syndrome Treatment Market, By Product Type :
Cyclosporine
Oral Corticosteroid
Artificial Tears
Omega Supplements
Punctual Bags
Others
Global Dry Eye Syndrome Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Supermarket/ Hypermarket
Other Stores
Online Pharmacies
Global Dry Eye Syndrome Treatment Market, By Region:
North America
By Product Type:
Cyclosporine
Oral Corticosteroid
Artificial Tears
Omega Supplements
Punctual Bags
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Supermarket/ Hypermarket
Other Stores
Online Pharmacies
By Country:
U.S.
Canada
Europe
By Product Type:
Cyclosporine
Oral Corticosteroid
Artificial Tears
Omega Supplements
Punctual Bags
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Supermarket/ Hypermarket
Other Stores
Online Pharmacies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product Type:
Cyclosporine
Oral Corticosteroid
Artificial Tears
Omega Supplements
Punctual Bags
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Supermarket/ Hypermarket
Other Stores
Online Pharmacies
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Cyclosporine
Oral Corticosteroid
Artificial Tears
Omega Supplements
Punctual Bags
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Supermarket/ Hypermarket
Other Stores
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type:
Cyclosporine
Oral Corticosteroid
Artificial Tears
Omega Supplements
Punctual Bags
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Supermarket/ Hypermarket
Other Stores
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Cyclosporine
Oral Corticosteroid
Artificial Tears
Omega Supplements
Punctual Bags
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Supermarket/ Hypermarket
Other Stores
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Allergan
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Bausch Health Companies, Inc.
Johnson and Johnson Vision Care Inc.
I-Med Pharma Inc
Santen Pharmaceuticals Co. Ltd.
AFT Pharmaceuticals
Novaliq GmBH
Otsuka Pharmaceutical Co. Ltd.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section